February 8, 2000Med-Pro, Inc. Recalls Esgic-Plus
Lexington, NE (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Med-Pro, Inc. is recalling Esgic-Plus Tablets
because the bottles contain capsule form of the same ingredient product, not the labeled
tablet form of product.
The recalled Esgic-Plus Tablets
(butalbital 50mg, acetaminophen 500mg, caffeine 40mg), was sold in 100 tablet bottles (NDC
#0456-0618-01) and distributed in New York.
According to FDA, 999 bottles were
distributed and can be identified by the Lot Number #90248A 1 EXP 8/01
This ongoing Class III recall
was initiated by Med-Pro, Inc. by fax on December 27, 1999. This is the first public
notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall D-210-0
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.